8-K: Earth Science Tech Elevates Transparency with OTCID Tier Listing

Earth Science Tech, Inc. announced its qualification for and listing on the newly launched OTCID tier of the OTC Markets, signaling enhanced disclosure and corporate governance.

Summary

• Earth Science Tech, Inc. (ETST) has qualified for and been listed on the newly launched OTCID tier of the OTC Markets.
• This listing signifies the company's adherence to enhanced disclosure, transparency, and compliance standards.
• The company believes this designation will increase investor confidence, attract new stakeholders, and support its strategic growth initiatives.
• ETST operates as a strategic holding company focused on acquiring, optimizing, and scaling high-potential operating businesses.
• Current operations include compounding pharmaceuticals, telemedicine, and real estate development through wholly-owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC, Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC, and an 80% interest in MagneChef.
• RxCompoundStore.com is licensed in Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Maine, Maryland, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Utah, Wisconsin, and Puerto Rico, and is actively pursuing licensure in remaining U.S. states.
• Mister Meds, acquired on October 1, 2024, received full compounding licensure in March 2025 and is applying for licensure in states not yet serviced by RxCompound.
• Peaks Curative, a telemedicine referral platform, has recently expanded into the veterinary market through the acquisition of Zoolzy.com.
• Avenvi, the real estate subsidiary, manages investment activities for ETST and oversees the company's ongoing $5 million share repurchase program.
• Earth Science Foundation Inc., a 501(c)(3) nonprofit, is the charitable arm of ETST, accepting grants and donations to assist individuals with prescription costs at RxCompound and Mister Meds.

Sentiment

Score: 8

Explanation: The document announces a significant positive development (OTCID listing) indicating enhanced transparency and compliance, coupled with management's optimistic outlook on the company's turnaround and future growth. The mention of a share repurchase program also adds to positive sentiment. No explicit negatives or delays are reported.

Positives

• Qualification for and listing on the new OTCID tier, indicating adherence to enhanced disclosure, transparency, and compliance standards.
• The company believes the OTCID designation will increase investor confidence, attract new stakeholders, and support strategic growth initiatives.
• Management stated the company has had an 'amazing turnaround in the last two years' and has a 'bright future'.
• RxCompoundStore.com is actively pursuing licensure in additional U.S. states.
• Mister Meds received full compounding licensure in March 2025 and is expanding its state licensure applications.
• Peaks Curative has expanded into the veterinary market through the acquisition of Zoolzy.com.
• Avenvi oversees an ongoing $5 million share repurchase program.

Risks

• Actual results may differ materially from intent, belief, or current expectations due to various risks and uncertainties.
• Risks include the markets for the company's products and services.
• Costs of goods and services.
• Other expenses.
• Government regulations.
• Litigations.
• General business conditions.

Future Outlook

The company believes its OTCID listing will increase investor confidence, attract new stakeholders, and support strategic growth initiatives. It aims to offer telemedicine services nationwide through licensure expansion and the development of its healthcare provider network. MagneChef is also in the process of expanding its product line for new offerings incorporating its intellectual property.

Management Comments

• "ETST has had an amazing turnaround in the last two years. The progress we have made is a testament to the hard work and dedication of everyone who works with us. We have a bright future." Giorgio R. Saumat, CEO and Chairman of the Board.

Industry Context

The move to the OTCID tier reflects a broader industry trend towards increased transparency and compliance standards for publicly traded companies, particularly those on OTC markets. This aims to enhance investor confidence and attract institutional investment by signaling a commitment to robust corporate governance, aligning with evolving regulatory expectations for market integrity and improved market access.

Comparison to Industry Standards

• The OTCID tier recognizes companies that meet enhanced disclosure, transparency, and compliance standards, positioning ETST among companies adhering to higher regulatory benchmarks within the OTC Markets.
• This move is comparable to other companies seeking to upgrade their listing tiers (e.g., from OTC Pink to OTCQB or OTCQX) to signal improved corporate governance and financial reporting quality, aiming to attract a broader investor base.
• While specific comparable companies or projects are not named, the qualification implies ETST has met the specific criteria set by OTC Markets for this new tier, which are designed to be more stringent than lower tiers.

Corporate Governance

Stakeholder Impact

• Shareholders/Investors: Increased investor confidence, potential attraction of new stakeholders, and support for strategic growth initiatives due to enhanced transparency and compliance from OTCID listing. The $5 million share repurchase program could also benefit shareholders.
• Customers: Continued and expanded access to compounding pharmaceuticals and telemedicine services through RxCompound, Mister Meds, Peaks Curative, Las Villas Health Care, and DOConsultations.
• Employees: Positive impact from the company's 'amazing turnaround' and 'bright future' as stated by the CEO, implying stability and growth opportunities.

Next Steps

• RxCompound is actively pursuing licensure in the remaining U.S. states.
• Mister Meds is currently applying for licensure in states not yet serviced by RxCompound.
• Peaks Curative aims to offer services nationwide through the development of its own healthcare provider network (MyOnlineConsultation.com) and ongoing licensure expansion for both pharmacies.
• MagneChef is in the process of expanding its product line for new offerings that incorporate its intellectual property.

Key Dates

Recommendation

Keywords

Earth Science Tech, ETST, OTC Markets, OTCID tier, compounding pharmacy, telemedicine, real estate development, RxCompoundStore, Mister Meds, Peaks Curative, Avenvi, MagneChef, corporate governance, investor relations, share repurchase program, healthcare, pharmaceuticals